Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Back

Neurological Surgery Spartanburg, SC Medical Doctor

NPI 1447540935 CMS profile 2903009

1330 Boiling Springs Rd Ste 1600, Spartanburg, SC 29303

Open in the dashboard

General payments

$98,880

301 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,155 paid to institutions, not to them · program year 2021

Through program year 2025, Adam Back of Spartanburg, SC is reported in the CMS Open Payments database as having received $98,880 across 301 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,155 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,078 30
2024 General $11,882 34
2023 General $15,149 51
2022 General $5,894 19
2021 General $8,572 40
2020 General $3,074 38
2019 General $43,230 89

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Back
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Adam Back were reported at $11,078. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Adam Back Neurological Surgery median Middle half National median
2019 $43,230 $582 $138–$3,006 $163
2020 $3,074 $294 $76–$2,174 $114
2021 $8,572 $387 $105–$2,432 $132
2022 $5,894 $542 $139–$2,989 $149
2023 $15,149 $534 $145–$2,697 $160
2024 $11,882 $574 $155–$3,046 $164
2025 $11,078 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $68,157 79 payments
  2. NuVasive, Inc. $19,050 139 payments
  3. Alphatec Spine, Inc $6,652 15 payments
  4. Boston Scientific Corporation $1,603 34 payments
  5. Providence Medical Technology, Inc. $1,203 15 payments
  6. SI-BONE, Inc. $877 4 payments
  7. Medtronic, Inc. $446 4 payments
  8. Orthofix Medical, Inc. $306 3 payments
  9. Spineology Inc. $280 2 payments
  10. Zimvie Inc. $128 1 payment
  11. Other $177 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $28,166 21 payments
  2. Travel and Lodging $22,595 56 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,400 5 payments
  4. Consulting Fee $14,950 11 payments
  5. Food and Beverage $9,569 207 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 1 payment
Products named General payments · program years 2019–2025
  1. RISE-L $11,654 7 payments
  2. RISE $11,257 7 payments
  3. CREO S2AI $11,189 7 payments
  4. CREO Orthopedics/Orthopedic Surgery $6,925 4 payments
  5. Other - Miscellaneous $6,243 11 payments
  6. XLIF $5,866 29 payments
  7. ALIF $5,808 15 payments
  8. MAGNIFY AL $5,000 3 payments
  9. EMPIRE (Expandable ALIF) $4,757 6 payments
  10. CREO Spine $4,690 4 payments
  11. Other $26,133 216 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

484

Median for Neurosurgery: 83

Drug cost

$3,937

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 202 $1,942
Methocarbamol Generic 155 $1,317
Oxycodone Hcl Generic 62 $390
Tizanidine Hcl Generic 22 $150
Methylprednisolone Generic 13 $74
Tramadol Hcl Generic 30 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$102,013

Medicare's payments for the services billed

Medicare patients

224

Average age 74

Services billed

662

135 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 44%
Ischemic heart disease 35%
Chronic kidney disease 30%
Depression 30%
Atrial fibrillation 25%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

301 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record